Transcatheter mitral valve-in-valve replacement transeptally using a novel balloon-expandable device.
cardiovascular research
valve repair/replacement
Journal
Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
revised:
20
05
2022
received:
11
04
2022
accepted:
04
06
2022
pubmed:
12
8
2022
medline:
8
9
2022
entrez:
11
8
2022
Statut:
ppublish
Résumé
We describe a patient with symptomatic severe mitral regurgitation, due to a failed 33-mm Epic (St. Jude Medical, St. Paul, MN) bioprosthetic heart valve surgically implanted 10-year before. For this specific purpose, we implanted a novel balloon-expandable transcatheter heart valve, the MyVal (Meril Life Science, Vapi, India). To the best of our knowledge, this is the second case describing the implantation of MyVal in a degenerative, surgically placed bioprosthesis.
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
3376-3377Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Belluschi I, Buzzatti N, Denti P, et al. First-in-man valve-in-valve with the new balloon-expandable Myval transcatheter heart valve in a failed sutureless perceval bioprosthesis. J Card Surg. 2021;36:2546-2548.
Sharma SK, Rao RS, Chandra P, et al. First-in-human evaluation of a novel balloon-expandable transcatheter heart valve in patients with severe symptomatic native aortic stenosis: the MyVal-1 study. EuroIntervention. 2020;16:421-429. doi:10.4244/EIJ-D-19-00413